Skip to main content
Have a personal or library account? Click to login
A Decade of Nasopharyngeal Carcinoma: Survival, Failure Patterns, and Prognostic Factors- A Single Institutional Experience Cover

A Decade of Nasopharyngeal Carcinoma: Survival, Failure Patterns, and Prognostic Factors- A Single Institutional Experience

Open Access
|Nov 2026
Read online

Abstract

Introduction

Nasopharyngeal carcinoma (NPC) is a distinct head and neck malignancy with complex management and a persistent risk of recurrence despite advances in radiotherapy (RT) and systemic therapy. We report a decade-long institutional experience from a lower-middle-income country (LMIC), evaluating survival outcomes, patterns of failure, and prognostic factors in patients treated with contemporary multimodality therapy.

Materials and Methods

This retrospective cohort study included 431 patients with histologically confirmed NPC treated with definitive RT between 2013 and 2023. RT was delivered using three-dimensional conformal radiotherapy (3DCRT) or intensity-modulated techniques, including IMRT or volumetric modulated arc therapy (VMAT). Chemotherapy was administered in induction, concurrent, and/ or adjuvant settings as clinically appropriate. Overall survival (OS) and recurrence-free survival (RFS) were estimated using the Kaplan-Meier method, and prognostic factors were analyzed using Cox proportional hazards regression.

Results

The median age was 48 years, with a predominance of advanced disease (91% stage III–IV). At a median follow-up of 61 months, 84.5% of patients were alive. The estimated 10-year OS and RFS were 71.2% and 55.6%, respectively. Multivariate Cox regression identified concurrent chemotherapy (HR = 0.411, p = 0.024) and advanced clinical stage (HR = 6.984, p = 0.021) as independent predictors of OS. Age ≥40 years and RT dose <65 Gy were independent adverse prognostic factors for RFS, whereas the VMAT technique was associated with improved RFS (p = 0.039). The Kaplan-Meier analysis supported the adverse prognostic impact of advanced clinical stage on survival.

Conclusion

Contemporary multimodality treatment was associated with favourable long-term survival in NPC despite advanced stage at presentation. Disease recurrence remains a major determinant of outcome, highlighting the need for optimized systemic strategies to further improve survival.

Language: English
Page range: 153 - 161
Published on: Nov 11, 2026
Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Anusha Haider, Syed Mohsin Raza, Sana Liaquat, Ahmed Ammar, Hamza Shakeel, Afshan Khanum, Asma Rashid, Zaheer Abbas, Muneeb Uddin Karim, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.